BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3522617)

  • 1. The dawn phenomenon does not occur in normal elderly subjects.
    Meneilly GS; Elahi D; Minaker KL; Rowe JW
    J Clin Endocrinol Metab; 1986 Aug; 63(2):292-6. PubMed ID: 3522617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dawn phenomenon: comparison between normal and insulin-dependent diabetic adolescents.
    Arslanian S; Ohki Y; Becker DJ; Drash AL
    Pediatr Res; 1992 Mar; 31(3):203-6. PubMed ID: 1313957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin does not alter insulin-mediated glucose disposal.
    Meneilly GS; Elahi D; Minaker KL; Rowe JW
    J Clin Endocrinol Metab; 1987 Aug; 65(2):364-7. PubMed ID: 2885337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of noninsulin-mediated glucose disposal in the elderly.
    Meneilly GS; Elahi D; Minaker KL; Sclater AL; Rowe JW
    J Clin Endocrinol Metab; 1989 Mar; 68(3):566-71. PubMed ID: 2563735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counterregulatory responses to insulin-induced glucose reduction in the elderly.
    Meneilly GS; Minaker KL; Young JB; Landsberg L; Rowe JW
    J Clin Endocrinol Metab; 1985 Jul; 61(1):178-82. PubMed ID: 3889037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of mild-to-moderate hyperglycaemia per se on glucose production and uptake in the elderly.
    Paolisso G; Marrazzo G; de Riu S; Sgambato S; Varricchio M; d'Onofrio F; Lefèbvre P
    Eur J Med; 1992 Apr; 1(1):6-12. PubMed ID: 1341981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin enhances insulin-mediated glucose disposal in elderly subjects.
    Meneilly GS; Elahi D; Minaker KL; Rowe JW
    J Clin Endocrinol Metab; 1988 Aug; 67(2):407-10. PubMed ID: 2899090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian variation of insulin requirement in insulin dependent diabetes mellitus the relationship between circadian change in insulin demand and diurnal patterns of growth hormone, cortisol and glucagon during euglycemia.
    Trümper BG; Reschke K; Molling J
    Horm Metab Res; 1995 Mar; 27(3):141-7. PubMed ID: 7607604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-mediated increase in blood flow is impaired in the elderly.
    Meneilly GS; Elliot T; Bryer-Ash M; Floras JS
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1899-903. PubMed ID: 7775638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure to detect the "dawn phenomenon" in nondiabetic subjects with markedly different patterns of nocturnal growth hormone secretion.
    Mauras N; Rogol AD; Clarke WL
    J Clin Endocrinol Metab; 1986 May; 62(5):975-9. PubMed ID: 3514653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.
    Campbell PJ; Bolli GB; Cryer PE; Gerich JE
    N Engl J Med; 1985 Jun; 312(23):1473-9. PubMed ID: 2859524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of glucose homeostasis in humans with denervated livers.
    Perseghin G; Regalia E; Battezzati A; Vergani S; Pulvirenti A; Terruzzi I; Baratti D; Bozzetti F; Mazzaferro V; Luzi L
    J Clin Invest; 1997 Aug; 100(4):931-41. PubMed ID: 9259593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes.
    Shapiro ET; Polonsky KS; Copinschi G; Bosson D; Tillil H; Blackman J; Lewis G; Van Cauter E
    J Clin Endocrinol Metab; 1991 Feb; 72(2):444-54. PubMed ID: 1991813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nocturnal blood glucose control in type I diabetes mellitus.
    Bolli GB; Perriello G; Fanelli CG; De Feo P
    Diabetes Care; 1993 Dec; 16 Suppl 3():71-89. PubMed ID: 8299480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects.
    Prager R; Wallace P; Olefsky JM
    J Clin Invest; 1986 Aug; 78(2):472-81. PubMed ID: 3525609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin?
    Soule S; Pemberton C; Hunt P; Cole D; Raudsepp S; Inder W
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):412-7. PubMed ID: 16181233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence of events during development of the dawn phenomenon in insulin-dependent diabetes mellitus.
    Campbell PJ; Bolli GB; Cryer PE; Gerich JE
    Metabolism; 1985 Dec; 34(12):1100-4. PubMed ID: 3906350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of a dawn phenomenon in normal adolescents.
    Arslanian S; Ohki Y; Becker DJ; Drash AL
    Horm Res; 1990; 34(1):27-32. PubMed ID: 1963621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.